Biotech visionary who left BMY and built a premier targeted oncology therapeutics platform – Clay Siegall of Seagen (SGEN)
Like tech, biotech entrepreneurs also have a wide variety of leaderships. However, given that most of the innovative companies often end up getting acquired by larger cap pharmaceutical companies, it…